Is TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 47.3% / 30% | 9.8% / 30% | 10.3% / 30% | 10.09% / 5% | ✗ NOT HALAL |
| DJIM | 47.3% / 33% | 9.8% / 33% | 10.3% / 33% | 10.09% / 5% | ✗ NOT HALAL |
| MSCI | 42.0% / 33% | 8.7% / 33% | 9.1% / 33% | 10.09% / 5% | ✗ NOT HALAL |
| S&P | 47.3% / 33% | 9.8% / 33% | 10.3% / 33% | 10.09% / 5% | ✗ NOT HALAL |
| FTSE | 42.0% / 33% | 8.7% / 33% | 9.1% / 50% | 10.09% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 51.8% | |
| Operating Margin | 27.3% | |
| Net Margin | 8.2% | |
| Return on Equity (ROE) | 20.8% | |
| Return on Assets (ROA) | 6.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1.6B |
| Free Cash Flow | $1.1B |
| Total Debt | $17.1B |
| Debt-to-Equity | 217.7 |
| Current Ratio | 1.0 |
| Total Assets | $40.7B |
Price & Trading
| Last Close | $29.78 |
| 50-Day MA | $32.30 |
| 200-Day MA | $24.13 |
| Avg Volume | 9.0M |
| Beta | 0.7 |
|
52-Week Range
$12.47
| |
About TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The company also focuses on the central nervous system (CNS), respiratory, and oncology areas. It provides active pharmaceutical ingredients, as well as contract manufacturing services; and operates an out-licensing platform that offers a portfolio of products to other pharmaceutical companies. The company also offers BENDEKA and TREANDA injections for the treatment of chronic lymphocytic leukemia and indolent b-cell non-hodgkin's lymphoma; COPAXONE to treat patients with relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine in adults; AUSTEDO to treat neurodegenerative and movement disorders chorea associated with Huntington's disease and tardive dyskinesia; UZEDY for the treatment of schizophrenia; ProAir RespiClick inhalation powder; QVAR RediHaler to treat asthma; BRALTUS, a long-acting muscarinic antagonist; CINQAIR/CINQAERO injection; DuoResp Spiromax budesonide and formoterol powder inhaler; and AirDuo RespiClick fluticasone propionate and salmeterol inhalation powder. The company offers its OTC products under the SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brand names. It has collaboration agreements with MedinCell S.A.; Sanofi; Alvotech; and Biolojic Design Ltd., as well as license agreement with MODAG GmbH. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), TEVA PHARMACEUTICAL INDUSTRIES LTD is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is TEVA PHARMACEUTICAL INDUSTRIES LTD's debt ratio?
TEVA PHARMACEUTICAL INDUSTRIES LTD's debt ratio is 47.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 42.0%.
What are TEVA PHARMACEUTICAL INDUSTRIES LTD's key financial metrics?
TEVA PHARMACEUTICAL INDUSTRIES LTD has a market capitalization of $33.5B, trailing P/E ratio of 23.8, and revenue of $17.3B. The company maintains a gross margin of 51.8% and a net margin of 8.2%. Return on equity stands at 20.8%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.